It is readily apparent that the COVID-19 pandemic has had an impact on transactional activity—at l

April 14, 2020

As COVID-19 continues to spread, so does its profound impact on all aspects of life and business, including M&A and private equity dealmaking. Whether you are a buyer, seller or adviser, it is critical to stay up to speed on what is proving to be a constantly evolving area. This special installment of Dealology will help you navigate some of the challenges faced with transactions in the time of the pandemic, including:

• Antitrust timing

• Rep & warranty insurance – availability, pricing, timing, exclusions, due diligence

• M&A and PE deal terms – purchase price, working capital target/peg, leverage, due diligence, material adverse effect

• The people factor